Cogent Biosciences Inc.

8.70-0.1100-1.25%Vol 64.52K1Y Perf -13.00%
Sep 23rd, 2021 14:02 DELAYED
BID8.68 ASK8.72
Open8.88 Previous Close8.81
Pre-Market- After-Market-
 - -%  - -
Target Price
19.83 
Analyst Rating
— — 0.00
Potential %
127.93 
Finscreener Ranking
★+     43.96
Insiders Trans % 3/6/12 mo.
-/-100/-100 
Value Ranking
★★     46.60
Insiders Value % 3/6/12 mo.
-/-100/-100 
Growth Ranking
★+     41.44
Insiders Shares Cnt. % 3/6/12 mo.
-/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
33.33 
Earnings Rating
Sell
Market Cap346.69M 
Earnings Date
8th Nov 2021
Alpha0.01 Standard Deviation0.79
Beta3.09 

Today's Price Range

8.678.97

52W Range

5.8314.44

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
6.02%
1 Month
-3.61%
3 Months
6.14%
6 Months
-2.65%
1 Year
-13.00%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
COGT8.70-0.1100-1.25
AAPL146.911.06000.73
GOOG2 841.2622.49000.80
MSFT299.971.39000.47
XOM57.131.92003.48
WFC48.070.99002.10
JNJ165.681.75001.07
FB346.703.49001.02
GE103.805.26005.34
JPM161.635.72003.67
Financial StrengthValueIndustryS&P 500US Markets
15.90
16.20
0.01
0.03
-
Leverage Ratio 2.40
ProfitabilityValueIndustryS&P 500US Markets
-
-31 649.70
-31 595.20
-407.40
-48.98
RevenueValueIndustryS&P 500US Markets
312.00K
0.01
-44.18
-23.18
Earnings HistoryEstimateReportedSurprise %
Q02 2021-0.39-0.43-10.26
Q01 2021-0.46-0.3426.09
Q04 2020-0.30-6.03-1 910.00
Q03 2020-0.19-0.26-36.84
Q02 2020-0.84-0.96-14.29
Q01 2020-1.32-0.8039.39
Q04 2019-1.400.28120.00
Q03 2019-1.24-1.56-25.81
Earnings Per EndEstimateRevision %Trend
9/2021 QR-0.43-10.26Negative
12/2021 QR-0.47-6.82Negative
12/2021 FY-1.62-11.72Negative
12/2022 FY-1.65-2.48Negative
Next Report Date8th Nov 2021
Estimated EPS Next Report-0.43
Estimates Count5
EPS Growth Next 5 Years %-
Volume Overview
Volume64.52K
Shares Outstanding39.85M
Shares Float37.35M
Trades Count803
Dollar Volume4.19M
Avg. Volume314.14K
Avg. Weekly Volume142.90K
Avg. Monthly Volume129.03K
Avg. Quarterly Volume255.78K

Cogent Biosciences Inc. (NASDAQ: COGT) stock closed at 8.81 per share at the end of the most recent trading day (a 0.23% change compared to the prior day closing price) with a volume of 79.54K shares and market capitalization of 346.69M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 72 people. Cogent Biosciences Inc. CEO is Andrews R. Robbins.

The one-year performance of Cogent Biosciences Inc. stock is -13%, while year-to-date (YTD) performance is -21.55%. COGT stock has a five-year performance of %. Its 52-week range is between 5.83 and 14.44, which gives COGT stock a 52-week price range ratio of 33.33%

Cogent Biosciences Inc. currently has a PE ratio of -0.60, a price-to-book (PB) ratio of 2.81, a price-to-sale (PS) ratio of 1 123.94, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -149.48%, a ROC of -248.99% and a ROE of -264.58%. The company’s profit margin is -48.98%, its EBITDA margin is -31 595.20%, and its revenue ttm is $312.00 Thousand , which makes it $0.01 revenue per share.

Of the last four earnings reports from Cogent Biosciences Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.43 for the next earnings report. Cogent Biosciences Inc.’s next earnings report date is 08th Nov 2021.

The consensus rating of Wall Street analysts for Cogent Biosciences Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Cogent Biosciences Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Cogent Biosciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Cogent Biosciences Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 22.81, ATR14 : 0.46, CCI20 : 161.88, Chaikin Money Flow : 0.04, MACD : 0.24, Money Flow Index : 53.80, ROC : 6.92, RSI : 60.72, STOCH (14,3) : 77.78, STOCH RSI : 0.74, UO : 62.91, Williams %R : -22.22), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Cogent Biosciences Inc. in the last 12-months were: John L. Green (Sold 17 813 shares of value $157 823 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary Rating---

Cogent Biosciences Inc.

Cogent Biosciences Inc is a biotechnology company. The company is engaged in the development of solutions to treat genetically driven diseases.

CEO: Andrews R. Robbins

Telephone: +1 617 945-5576

Address: 200 Cambridge Park Drive, Cambridge 02140, MA, US

Number of employees: 72

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

62%38%

Bearish Bullish

53%47%

Bearish Bullish

48%53%

News

Stocktwits